A detailed history of Marathon Trading Investment Management LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Marathon Trading Investment Management LLC holds 14,400 shares of CCCC stock, worth $86,400. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,400
Previous 64,000 77.5%
Holding current value
$86,400
Previous $522,000 87.36%
% of portfolio
0.02%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.05 - $8.1 $200,880 - $401,760
-49,600 Reduced 77.5%
14,400 $66,000
Q1 2024

May 10, 2024

BUY
$5.3 - $11.0 $339,200 - $704,000
64,000 New
64,000 $522,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $293M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.